Edwards Lifesciences
€10,000 invested in 2016 · with dividend reinvestment
This company does not pay dividends
This company reinvests profits fully into growth and innovation. Investors benefit exclusively from share price appreciation.
View dividend-paying stocksAbout Edwards Lifesciences
Edwards Lifesciences Corporation is a medical technology company focused on structural heart disease and advanced cardiovascular care. The company develops and markets transcatheter heart valve replacement systems, surgical heart valves, and repair technologies used in procedures for aortic, mitral, and tricuspid valve conditions. Its portfolio also includes hemodynamic monitoring solutions that help clinicians assess cardiovascular function in hospital settings. Edwards Lifesciences serves hospitals, cardiac specialists, and healthcare systems across major global markets, with products designed for both minimally invasive and surgical applications. Headquartered in Irvine, California, Edwards Lifesciences plays a significant role in the cardiovascular device market through specialized therapies and diagnostic tools used in the treatment of complex heart disease.